CClinicalTrials.gg
CompletedNCT03254693RCTUpdated Aug 29, 2017

BONDING TO ENAMEL USING A UNIVERSAL ADHESIVE

A Phase 4 interventional study of 1-step self-etch approach (SE) and selective enamel etching (SEE) in Clinical Trial, sponsored by Universidade Estadual de Ponta Grossa. Completed at 1 site in Brazil. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-08-29.

Sponsored by Universidade Estadual de Ponta Grossa · Phase 4, Interventional, and Other

Phase
Phase 4
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Objective: This double-blind randomized clinical trial evaluates strategies for improving the bonding of universal adhesive to enamel in non-carious cervical lesions (NCCL) of a new universal multi-mode adhesive (Ambar Universal; FGM).

Methods: A total of 134 restorations were randomly placed in 19 patients according to the following groups: SE - Self-etch; SEE - Selective etching; SE2X - Self-etch doble time; SE1+ - Self-etch additional layer. The resin composite Opallis (FGM) was placed incrementally. The restorations were evaluated after one week (baseline), 6 and 12 months, using the FDI and USPHS criteria. Statistical analyses were performed using appropriate tests (=0.05).

Read the detailed description

Interventions: restorative procedure All the patients selected for this study received dental prophylaxis with a suspension of pumice and water in a rubber cup and signed an informed consent form two weeks before the restorative procedures.

The degree of sclerotic dentin from the NCCLs was measured according to the criteria described by Swift and others. The cavity dimensions in millimeters (height, width, and depth), the geometry of the cavity (evaluated by profile photograph and labeled at \<45o, 45o-90o, 90o\<135o, and >135o), the presence of an antagonist, and the presence of attrition facets were observed and recorded. Pre-operative sensitivity was also evaluated by applying air for 10 s from a dental syringe placed 2 cm from the tooth surface and with an explorer. These features were recorded to allow comparison of the baseline features of the dentin cavities among experimental groups.

To calibrate the restorative procedure, the study director placed one restoration of each group to identify all steps involved in the application technique. Then, the two operators, who were resident dentists with more than five years of clinical experience in operative dentistry, placed four restorations, one of each group, under the supervision of the study director in a clinical setting. The restoration failures were shown to the operators prior to starting the study. At this point, the operators were considered calibrated to perform the restorative procedures.

The operators restored all teeth. All participants received four restorations, one of each experimental group in different lesions previously selected according to the inclusion criteria.

Before restorative procedures, the operators anesthetized the teeth with a 3% mepivacaine solution (Mepisv, Nova DFL, Rio de Janeiro, RJ, Brazil) and cleaned all lesions with pumice and water in a rubber cup, followed by rinsing and drying. Then, shade selection was made using a shade guide.

Cleaning of all lesions with pumice and water in a rubber cup was carried out, followed by rinsing and drying. Using a shade-selection guide, the proper shade of the composite was determined. Following the ADA guidelines, the operators did not prepare any additional retention or bevel.

The NCCLs received the multimode adhesive system applied in different modes: 1-step self-etch approach (SE), selective enamel etching (SEE), 1-step self-etch applied for double time in the enamel (SE2X), 1-step self-etch approach with additional layer (SE1+) was applied as described below. The compositions, more details regarding the adhesion strategies used and batch numbers are described in Table 2.

The adhesives were light-cured with a LED light-curing unit (1,000 mW/cm2) (Radii-cal), according to the manufacturer's instructions (Table 2). Opallis (FGM) composite resin was used in 2 to 3 increments, each one being light-cured (Radii-cal) for 30 s. The restorations were finished immediately with fine #2200 diamond burs (KG Sorensen). Polishing was performed with rubber points (Astropol, Ivoclar Vivadent, Liechtenstein).

02

Conditions studied

  • Clinical Trial

Keywords

  • Non-carious cervical lesions; Universal system; Longevity.
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants had to be in good general health.
  • At least 18 years old
  • Have an acceptable oral hygiene level
  • Present at least 20 teeth under occlusion
  • At least four NCCLs in four different teeth
  • These lesions had to be non-carious, non-retentive, deeper than 1 mm, and involve both the enamel and dentin of vital teeth without mobility.
  • The cavo-surface margin could not involve more than 50% of enamel, and all lesions had cervical margins ending in dentin.

Exclusion criteria

Exclusion Criteria:

  • Participants had not be in good general health.
  • At less 18 years old
  • Have not an acceptable oral hygiene level
  • Present at less 20 teeth under occlusion
  • At less four NCCLs in four different teeth, these lesions had not be non-carious, retentive and involve only enamel of vital teeth with mobility.
04

Study design

Phase
Phase 4
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
35 participants (actual)

Study arms

  • Active comparator
    1-step self-etch approach (SE)

    According to the manufacturer's instructions.

    Combination Product: 1-step self-etch approach (SE)

  • Active comparator
    selective enamel etching (SEE)

    According to the manufacturer's instructions.

    Combination Product: selective enamel etching (SEE)

  • Experimental
    1-step self-etch for double time (SE2X)

    According to the manufacturer's instructions, but for the double time (20 s) in the each application.

    Other: 1-step self-etch for double time (SE2X)

  • Experimental
    1-step self-etch additional layer (SE1+)

    According to the manufacturer's instructions, but apply tree times.

    Other: 1-step self-etch additional layer (SE1+)

Interventions

  • Combination product1-step self-etch approach (SE)

    Application mode - Do not use etchan. According to the manufacturer's instructions.

    Also known as: SE

  • Combination productselective enamel etching (SEE)

    Application mode - Etch only on enamel for 15 s. Rinse for 15s. Air dry to remove excess water.According to the manufacturer's instructions.

    Also known as: SEE

  • Other1-step self-etch for double time (SE2X)

    Application mode - Do not use etchan. According to the manufacturer's instructions, but for the double time (20 s) in the each application.

    Also known as: SE2X

  • Other1-step self-etch additional layer (SE1+)

    Application mode - Do not use etchan. According to the manufacturer's instructions, but apply tree times.

    Also known as: SE1+

05

What researchers measure

Primary outcomes

  1. Retention

    The primary clinical endpoint was restoration retention/fracture.

    Time frame: 6 montths

Secondary outcomes

  1. Marginal Adaptation

    Restoration marginal adaptation.

    Time frame: 6 months

06

Study locations

1 site
  • Universidade Estadual do Oeste do Paraná
    Cascavel, Paraná 85819-110, Brazil
07

Registry details

Key details

Study ID
NCT03254693
Lead sponsor
Universidade Estadual de Ponta Grossa
Collaborators
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Responsible party
Eloisa Andrade de Paula (Doctor, Universidade Estadual do Oeste do Paraná) — Principal investigator
First posted
Aug 18, 2017
Start date
Feb 1, 2016
Primary completion
Aug 1, 2017
Completion
Aug 1, 2017
Last update
Aug 29, 2017

Study contacts

Rafael Scheffer, Master
study chair · Universidade Estadual do Oeste do Paraná

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion